Biostage

Biostage is a bioengineering company developing the next generation of esophageal implants. The company's Cellspan technology combines a proprietary biocompatible scaffold with the patient's own cells to create an esophageal implant for treating pediatric esophageal atresia and other conditions affecting the esophagus. The company’s esophageal implant leverages the body’s inherent self-healing ability to promote regeneration of esophageal tissue and elicit a positive host response, resulting in a tissue-engineered new conduit that restores the continuity of the esophagus. These implants have the potential to significantly improve the quality of life for both children and adults.